Kevin Bennett, Associate Professor in Biology offers novel, sensitive molecular imaging contrast agents to market.
Nanodiagnostics, LLC was recently established out of the lab of Kevin Bennett, Associate Professor in Biology. Nanodiagnostics brings novel, sensitive molecular imaging contrast agents to market. Nanodiagnostics will also offer structural and molecular imaging services for clinical and preclinical studies. Nanodiagnostics' latest technology enables large-scale studies of kidney morphology, which is important for understanding and detecting diabetic nephropathy, drug-induced nephropathy, and for visualizing the action of newly-discovered drugs.